| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5596834 | The Annals of Thoracic Surgery | 2017 | 7 Pages |
Abstract
Albumin restriction in the cardiac surgery intensive care unit was feasible and safe. Significant reductions in utilization and cost with no changes in morbidity or mortality were demonstrated. These findings may provide a strategy for reducing cost while maintaining quality of care.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Joseph MD, Timothy DNP, CRNP, Ashleigh V. PharmD, Michael BS, James S. MD, Daniel MD,